Loading stock data…
SCLX
$10.58+0.06 (+0.57%)
Market ClosedLast close May 1
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Scilex Holding Company in the Healthcare sector is trading at $10.58. The stock is currently 69% below its 52-week high of $34.27, remaining 24.8% below its 200-day moving average. Technical signals show overbought RSI of 88 and bullish MACD crossover, explaining why SCLX maintains its current current market pressure. The Whystock Score of 10/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 88) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.58
Potential Upside
5%
Whystock Fair Value$11.11
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescript...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$50.92M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.42
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
187.68%
Volume
Today's trading volume
137,672
Recent News
Datavault AI Signs Binding Term Sheet for $120 Million Cash Contribution From Scilex
Datavault AI (DVLT) said Monday it has signed a binding term sheet for a cash contribution and reven
Trending tickers: Datavault, Novo Nordisk, FedEx, SBI and NatWest
The latest investor updates on stocks that are trending on Monday
Scilex Holding Company's (NASDAQ:SCLX) top owners are retail investors with 57% stake, while 24% is held by private companies
Key Insights Scilex Holding's significant retail investors ownership suggests that the key decisions are influenced by...
Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
Datavault AI's multi-million-dollar geothermal deal and guidance upgrade signal that its strategic pivot to AI data monetization is gaining traction.
Datavault AI Aims For $200 Million In 2026
Bigger deals and global expansion give management fresh confidence